Literature DB >> 11953374

Identification and cloning of a cryptococcal deacetylase that produces protective immune responses.

Carmelo Biondo1, Concetta Beninati, Demetrio Delfino, Marco Oggioni, Giuseppe Mancuso, Angelina Midiri, Mauro Bombaci, Giuseppe Tomaselli, Giuseppe Teti.   

Abstract

Cell-mediated immunity plays a crucial role in host defenses against Cryptococcus (Filobasidiella) neoformans. Therefore, the identification of cryptococcal antigens capable of producing T-cell-mediated responses, such as delayed-type hypersensitivity (DTH) reactions, may be useful in the development of immune-based strategies to control cryptococcosis. In order to characterize DTH-producing antigens, culture supernatants from the unencapsulated Cap-67 strain were separated by anion-exchange chromatography. After further fractionation by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a purified protein with an apparent molecular mass of 25 kDa was found to produce DTH, as evidenced by increased footpad swelling in mice immunized with culture supernatants, relative to unimmunized mice. The 20-amino-acid N-terminal sequence of the 25-kDa protein was used to search data of the C. neoformans Genome Project. Based on the genomic DNA sequence, a DNA probe was used to screen a lambda cDNA library prepared from strain B3501. Clones were isolated containing the full-length gene (d25), which showed homology with a number of polysaccharide deacetylases from fungi and bacteria. The recombinant d25 protein expressed in Escherichia coli was similar to the natural one in DTH-producing activity. Moreover, immunization with either the natural or the recombinant protein prolonged survival and decreased fungal burden in mice challenged with the highly virulent C. neoformans strain H99. In conclusion, we have described the first cryptococcal gene whose product, a 25-kDa extracellular polysaccharide deacetylase, has been shown to induce protective immunity responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953374      PMCID: PMC127888          DOI: 10.1128/IAI.70.5.2383-2391.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  BCM Search Launcher--an integrated interface to molecular biology data base search and analysis services available on the World Wide Web.

Authors:  R F Smith; B A Wiese; M K Wojzynski; D B Davison; K C Worley
Journal:  Genome Res       Date:  1996-05       Impact factor: 9.043

2.  Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components.

Authors:  D Delfino; L Cianci; E Lupis; A Celeste; M L Petrelli; F Curró; V Cusumano; G Teti
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole.

Authors:  R K Li; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

4.  Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells.

Authors:  W Chaka; A F Verheul; V V Vaishnav; R Cherniak; J Scharringa; J Verhoef; H Snippe; I M Hoepelman
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

5.  Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response.

Authors:  J W Murphy
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.

Authors:  C H Mody; R Paine; C Jackson; G H Chen; G B Toews
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

7.  Protective murine monoclonal antibodies to Cryptococcus neoformans.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis.

Authors:  J W Murphy; N Pahlavan
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.

Authors:  S M Muth; J W Murphy
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Purification and characterization of chitin deacetylase from Absidia coerulea.

Authors:  X D Gao; T Katsumoto; K Onodera
Journal:  J Biochem       Date:  1995-02       Impact factor: 3.387

View more
  18 in total

1.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

2.  Unique subsite specificity and potential natural function of a chitosan deacetylase from the human pathogen Cryptococcus neoformans.

Authors:  Lea Hembach; Martin Bonin; Christian Gorzelanny; Bruno M Moerschbacher
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-03       Impact factor: 11.205

3.  Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans.

Authors:  Lorina G Baker; Charles A Specht; Maureen J Donlin; Jennifer K Lodge
Journal:  Eukaryot Cell       Date:  2007-03-30

4.  Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.

Authors:  Chao Huang; Shu-Hua Nong; Michael K Mansour; Charles A Specht; Stuart M Levitz
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

5.  Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans.

Authors:  Carmelo Biondo; Concetta Beninati; Mauro Bombaci; Luciano Messina; Giuseppe Mancuso; Angelina Midiri; Roberta Galbo; Giuseppe Teti
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

6.  Protective efficacy of antigenic fractions in mouse models of cryptococcosis.

Authors:  Michael K Mansour; Lauren E Yauch; James B Rottman; Stuart M Levitz
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

7.  A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.

Authors:  Mattie Young; Sandra Macias; Derek Thomas; Floyd L Wormley
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984

Review 8.  Virulence-Associated Enzymes of Cryptococcus neoformans.

Authors:  Fausto Almeida; Julie M Wolf; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2015-10-09

Review 9.  A Call to Arms: Quest for a Cryptococcal Vaccine.

Authors:  Marley C Caballero Van Dyke; Floyd L Wormley
Journal:  Trends Microbiol       Date:  2017-11-02       Impact factor: 17.079

10.  Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Sailatha Ravi; Sandra Macias; Mattie L Young; Michal A Olszewski; Chad Steele; Floyd L Wormley
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.